In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

EHRA Website for Patients

Discover and share afibmatters.org with your patients to help them understand atrial fibrillation, the signs, symptoms and treatments in English, French, German, Italian, Spanish, Swedish, Portuguese and recently Russian.

Read more
NEW Apps for Atrial Fibrillation

Revolutionise your management of AF patients with two new apps. Download the 'AF Manager' and tell your patients about the 'My AF' app.

Access apps

Practice Guideline Track on Atrial Fibrillation

Guidelines into Practice

Cardiovascular Pharmacology and Pharmacotherapy
Invasive Electrophysiology and Ablation
Atrial Fibrillation


Contributor: Special thanks to Dipak Kotecha

Based on the ESC Clinical Practice Guidelines on Atrial Fibrillation (Management of) 2016

Webinars on this topic

 ESC webinar on "New ESC guidelines for atrial fibrillation: future trends for AF and its neurological complications, the impact of anticoagulation and ablation"  streamed live on 15 December 2016:  Watch the recording. 

Part 1 - Overview of the Guidelines

Session title Slides Webcast
ESC Clinical Practice Guidelines: Atrial fibrillation - Part 1    
ESC Clinical Practice Guidelines: Atrial fibrillation - Part 2    
First presentation of atrial fibrillation: Initial approach, goals, and expectations    
The atrial fibrillation heart team approach to stroke prevention: risk stratification and stroke prevention    
The atrial fibrillation heart team approach to stroke prevention: managing complications    
The atrial fibrillation heart team approach to rate control    
The atrial fibrillation heart team approach to antiarrhythmic drugs and catheter ablation    
The atrial fibrillation heart team approach to atrial fibrillation surgery    
Meet the Guidelines Task Force - Atrial fibrillation    

Part 2 - Topics in focus

Topic/Section Session title Slides Webcast
Screening for atrial fibrillation to prevent stroke Atrial fibrillation Symposium joint with the Lancet    
Rate control Atrial fibrillation Symposium joint with the Lancet    
Treating low-risk patients with nonvalvular AF Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry    
Early mortality in newly diagnosed nonvalvular AF Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry    
State of the art in catheter ablation of atrial fibrillation Can we maintain sinus rhythm by catheter ablation?    
Are you still afraid about bleeding risk of antithrombotic therapy in atrial fibrillation? Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR    
ESC-EURObservational Research Programme: In-hospital and 1-year follow-up of the Long-term Atrial Fibrillation Ablation Registry, Conducted by the European Heart Rhythm Association Registries atrial fibrillation    
Association of Inappropriate Dosing of Non-Vitamin K Oral Anticoagulants and Risk of Adverse Events: Results from the ORBIT-AF II Registry Registries atrial fibrillation    
State of the art in treatment of acute coronary syndrome patients in need of oral anticoagulation Challenges with anticoagulants and antithrombotics in acute coronary syndrome    
How to define non-valvular atrial fibrillation? Atrial fibrillation in clinical practice    
Heart failure and atrial fibrillation: which comes first? Atrial fibrillation in clinical practice    
The AF epidemic and AF ablation treatment options in 2016: a clinical evidence review Creating a new landscape in AF ablation and the impact on clinical practice    
Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications    
Anticoagulation in patients with atrial fibrillation: challenges with continuing protection from hospital to home Practical management of patients with atrial fibrillation – Individualised approaches to stroke prevention    
Day-to-day management of patients with atrial fibrillation on non-VKA oral anticoagulant therapy – Practical perspectives Interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation    
Gender differences in clinical presentation and predictors of one-year outcomes in atrial fibrillation Clinical features and management of atrial fibrillation    
Ideal AF ablation candidate and when do I refer? Creating a new landscape in AF ablation and the impact on clinical practice    
The management of patients with atrial fibrillation and renal impairment – Practical perspectives Interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation    

 

Clinical cases on this topic